Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Horizons in the Treatment of Vitreous Floaters: Efficacy and Safety of Vitreolysis With the Ultra Q Reflex YAG Laser (Ellex)

NCT02812004 is registered in ClinicalTrials.gov with Augenabteilung Allgemeines Krankenhaus Linz as lead sponsor.

NCT NCT02812004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02812004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Horizons in the Treatment of Vitreous Floaters: Efficacy and Safety of Vitreolysis With the Ultra Q Reflex YAG Laser (Ellex)
Lead sponsor
Augenabteilung Allgemeines Krankenhaus Linz
Phase
Phase 4
Overall status
Unknown status
Start date
July 31, 2016
Completion date
October 31, 2017
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

other vitreous opacities, bilateral